198 related articles for article (PubMed ID: 32886316)
1.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
2.
O'Shea PM; O'Donoghue D; Bashari W; Senanayake R; Joyce MB; Powlson AS; Browne D; O'Sullivan GJ; Cheow H; Mendichovszky I; Quill D; Lowery A; Lappin D; Gurnell M; Dennedy MC
Clin Endocrinol (Oxf); 2019 May; 90(5):670-679. PubMed ID: 30721535
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
5. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
6. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.
Puar TH; Khoo CM; Tan CJ; Tong AKT; Tan MCS; Teo AE; Ng KS; Wong KM; Reilhac A; O'Doherty J; Gomez-Sanchez CE; Kek PC; Yee S; Tan AWK; Chuah MB; Lee DHM; Wang KW; Zheng CQ; Shi L; Robins EG; Foo RSY;
J Hypertens; 2022 Jun; 40(6):1179-1188. PubMed ID: 35703880
[TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging in the diagnosis of primary aldosteronism.
Powlson AS; Gurnell M; Brown MJ
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):150-6. PubMed ID: 25871964
[TBL] [Abstract][Full Text] [Related]
8. Para-chloro-2-[
Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
[No Abstract] [Full Text] [Related]
9. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
10. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
12. Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.
Mendichovszky IA; Powlson AS; Manavaki R; Aigbirhio FI; Cheow H; Buscombe JR; Gurnell M; Gilbert FJ
Diagnostics (Basel); 2016 Nov; 6(4):. PubMed ID: 27869719
[TBL] [Abstract][Full Text] [Related]
13. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
Hennings J; Sundin A; Hägg A; Hellman P
Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
[TBL] [Abstract][Full Text] [Related]
14. Lateralization in
Isojärvi J; Viukari M; Pörsti I; Leijon H; Vesterinen T; Seppänen M; Nevalainen PI; Matikainen N
Endocrinol Diabetes Metab; 2022 Nov; 5(6):e368. PubMed ID: 36039035
[TBL] [Abstract][Full Text] [Related]
15. Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
Lu CC; Chen CJ; Peng KY; Chueh JS; Chang CC; Yen RF; Wu VC;
Clin Nucl Med; 2022 Nov; 47(11):936-942. PubMed ID: 36215396
[TBL] [Abstract][Full Text] [Related]
16. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
17. The role of PET in localization of neuroendocrine and adrenocortical tumors.
Eriksson B; Bergström M; Sundin A; Juhlin C; Orlefors H; Oberg K; Långström B
Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551
[TBL] [Abstract][Full Text] [Related]
18. [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].
Juhlin C; Törnblom S; Rastad J; Bergström M; Bonasera T; Sundin A; Långström B
Nord Med; 1998 Nov; 113(9):306-7. PubMed ID: 9835764
[TBL] [Abstract][Full Text] [Related]
19. Functional imaging by 11C-metomidate PET: a really useless technique for primary aldosteronism subtyping?
Crimì F; Spimpolo A; Cecchin D; Rossi GP
Eur J Endocrinol; 2021 Mar; 184(3):L9-L10. PubMed ID: 33555270
[No Abstract] [Full Text] [Related]
20. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
